Trials / Completed
CompletedNCT01768468
To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients
Double Blinded, Randomized, Active Drug Comparative, Multi-center, Phase IV Clinical Study to Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- PMG Pharm Co., Ltd · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind study to compare the efficacy and safety of LAYLA tablet and Joins tablet in the treatment of osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LAYLA tablet | 1 tablet twice a day |
| DRUG | JOINS tablet | 1 tablet at each time, 3 times a day |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-09-01
- First posted
- 2013-01-15
- Last updated
- 2013-10-14
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01768468. Inclusion in this directory is not an endorsement.